This finding could have important implications in the regulation of inflammation, as CXCR1 agonists could operate as selective anti-inflammatory agents by preventing the activation of CXCR2, which is responsible for the accumulation of neutrophils into inflamed tissues due to injury or infection [4]. This evidence concerns the gene CXCR1 and infection.